Zhongnan Medical Journal Press

Home Results

A total of 16 result was found. Results that relate to Rapid health technology assessment

Rapid health technology assessment of anlotinib in treatment of advanced non-small cell lung cancer

Published on New Medicine 2021,31(1):350-356.
6727 times 2402 times

Shan SHEN Jie YANG Yun-Xia LIU Hai-Ming MA Ning HOU

Anlotinib Advanced non-small cell lung cancer Rapid health technology assessment
Details
Clinical comprehensive evaluation of albumin-bound paclitaxel in the treatment of metastatic pancreatic cancer

Published on Chinese Journal of Pharmacoepidemiology 2023,32(3):294-304.
1951 times 857 times

Xin-Cai ZHAO Yao QIU Wan-Hu ZHU Rong XU Cheng GUO Jian-Ping ZHANG

Albumin-bound paclitaxel Metastatic pancreatic cancer Clinical comprehensive evaluation Rapid health technology assessment
Details
Teriparatide treatment for osteoporosis: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2024,33(1):75-84.
780 times 476 times

LYU Peng ZHANG Jingli WAN Yuansheng HUANG Yifei YOU Ruxu

Teriparatide Osteogenesis Safety Effectiveness Economy Rapid health technology assessment
Details
Dapagliflozin in the treatment of chronic heart failure: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2023,32(5):554-563.
3280 times 801 times

An-Hua WEI Lu WANG Lu ZENG Xue-Peng GONG Dong LIU

Dapagliflozin Chronic heart failure Effectiveness Safety Economy Rapid health technology assessment
Details
Rapid health technology assessment of dulaglutide for the treatment of type 2 diabetes mellitus

Published on Chinese Journal of Pharmacoepidemiology 2023,32(8):931-940.
1880 times 560 times

Yuan YAO Fen-Li SU Xu SUN Shi-Yin FENG Fen XIONG Qing-Qun CAI

Dulaglutide Type 2 diabetes mellitus Rapid health technology assessment
Details
Alirocumab in the treatment of hypercholesterolemia: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2023,32(12):1388-1400.
1208 times 476 times

Jian-Cheng ZHOU Chun-Mei JI Wen-Tong FANG Ying ZOU Yong-Qing WANG Yuan-Yuan FU

Alirocumab Hypercholesterolemia Safety Efficacy Cost-effectiveness Rapid health technology assessment
Details
Dexmedetomidine for sedation in the ICU patients on mechanical ventilation: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2024,33(4):441-448.
1081 times 1201 times

LI Wenping DENG Pingyang YANG Lin DU Xian CAI Jiangxia

Dexmedetomidine Intensive care unit Mechanical ventilation Sedation Rapid health technology assessment
Details
Argatroban in the treatment of acute ischemic stroke: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2024,33(5):549-560.
1276 times 507 times

ZHUANG Zhijiang ZHANG Qiang CHEN Zhijia ZHANG Lihong

Argatroban Acute ischemic stroke Rapid health technology assessment
Details
Ertugliflozin in the treatment of type 2 diabetes mellitus: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2024,33(7):778-789.
1204 times 286 times

QIN Fang WU Kunrong LIU Chengyu LIU Daihua

Ertugliflozin Type 2 diabetes mellitus Efficacy Safety Cost-effectiveness Rapid health technology assessment
Details
First-line treatment with tislelizumab for advanced non-small cell lung cancer: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2024,33(7):790-800.
1107 times 242 times

LI Wenyan PAN Xiding JIE Qiong LI Yuanyuan TANG Mufei

Tislelizumab Non-small cell lung cancer First-line treatment Rapid health technology assessment
Details
Romiplostim for the treatment of primary immune thrombocytopenia in adults: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2024,33(8):909-918.
962 times 285 times

LI Jie XIE Jun HAN Yi MENG Ying GAO Liyuan SHI Xiaohui JIANG Zhitao

Romiplostim Primary immune thrombocytopenia Efficacy Safety Economic Rapid health technology assessment
Details
CDK4/6 inhibitors in the first-line treatment of HR+/HER2- advanced stage breast cancer: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2024,33(9):1017-1029.
882 times 191 times

LI Anna XIA Zhengzheng CAI Jiali LIAN Zhuoshi MENG Jun

CDK4/6 inhibitors Endocrine therapy HR+/HER2- advanced breast cancer Rapid health technology assessment
Details
Four intravenous iron formulations in the treatment of iron deficiency anemia: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2024,33(9):1030-1043.
866 times 191 times

XING Zhicong SUN Fudong XUE Qingxia ZHANG Bei MU Shengjun ZHAO Quan

Iron sucrose Iron dextran Ferric carboxymaltose Iron isomaltoside Iron deficiency anaemia Rapid health technology assessment
Details
HLA-B*5801 gene polymorphisms detection in prediction of severe drug eruption associated allopurinol: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2024,33(9):1044-1053.
950 times 202 times

CAO Jinjin LING Ya ZHANG Jie ZHANG Jingjing ZHU Jianguo CAO Xiufang

Allopurinol HLA-B*5801 gene testing Severe drug eruption Rapid health technology assessment
Details
Edaravone in the treatment of acute ischemic stroke: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2024,33(10):1147-1155.
311 times 59 times

YU Fang ZENG Lu WEI Anhua GONG Xuepeng WANG Lu

Edaravone Acute ischemic stroke Efficacy Safety Economy Rapid health technology assessment
Details